|
|
The Use of Mesalamine Suppositories in Patients with Mild to Moderate Ulcerative Proctitis | |||||||||||||||
|
|
||||||||||||||||
|
Dr.
Mark Lamet, from the Center for Gastrointestinal Disorders in Hollywood,
Florida, discusses the symptoms, epidemiology, and management of ulcerative
proctitis. He focuses on the treatment options for this condition, paying
particular attention to the use of topical 5-aminosalicylic acid (5-ASA)
as first-line therapy, the extent of therapeutic efficacy with the use
of suppositories, and a comparison of a new strength of mesalamine suppositories
(1 g h.s.) with standard dosing.
Approx.
11 minutes |
|||||||||||||||
|
|
||||||||||||||||
| For details on how to download and install this presentation, click here. | ||||||||||||||||
| Return to Main | ||||||||||||||||